We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Portola, Bristol-Myers, Pfizer Collaborate to Investigate Anticoagulant Antidote
Portola, Bristol-Myers, Pfizer Collaborate to Investigate Anticoagulant Antidote
November 2, 2012
Portola Pharmaceutical, Bristol-Myers Squibb Company and Pfizer have signed a clinical collaboration agreement to study a universal Factor Xa inhibitor antidote, PRT4445, and Eliquis (apixaban). Pharmaceutical Business Review
